EUVIMEDEUVIMED entdecken
Crossref

Pharmaceutical products liability in the United Kingdom

James Goudkamp

Pharmaceuticals Policy and Law · 2018-12 · 20 (1-4) · 115-129

DOI: 10.3233/ppl-180469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals Policy and Law, 2018-12. Verfasst von James Goudkamp. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This short article addresses a series of questions regarding pharmaceutical products liability in the United Kingdom. Issues in both the relevant substantive and procedural law are discussed. The overall picture that emerges is that claims for damage caused by pharmaceutical products are exceptionally challenging. This is due not only, in particular, to a general reluctance on the part of judges to find fault in the design of pharmaceutical products but also the exceptionally high cost of litigation in the United Kingdom.

Zitieren

APA

Goudkamp, J. (2018). Pharmaceutical products liability in the United Kingdom. Pharmaceuticals Policy and Law, 20(1-4), 115-129. https://doi.org/10.3233/ppl-180469

Vancouver

Goudkamp J. Pharmaceutical products liability in the United Kingdom. Pharmaceuticals Policy and Law. 2018;20(1-4):115-129. doi:10.3233/ppl-180469

BibTeX
@article{Goudkamp2018,
  author = {Goudkamp, James},
  title = {Pharmaceutical products liability in the United Kingdom},
  journal = {Pharmaceuticals Policy and Law},
  year = {2018},
  volume = {20},
  number = {1-4},
  pages = {115--129},
  doi = {10.3233/ppl-180469}
}
Kostenlos starten →